Product Program year 2023 Source: CMS Open Payments

Arthrex

Device Arthroplasty - Implants - Revers Total Shoulder - Revers

PDI 00888867234215

Open in the dashboard

General payments

$9,090,817

36 payments

Research payments

$0

0 payments

Through program year 2023, $9,090,817 in general payments and $0 in research payments were reported against Arthrex (Revers Total Shoulder - Revers).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2023 General $1,453,609 5
2022 General $5,459,869 18
2021 General $2,177,338 13

Breakdown

Who paid General payments · program years 2021–2023
  1. Arthrex, Inc. $9,090,817 36 payments
Top recipients General payments · program year 2023
  1. Anthony Romeo Orthopaedic Surgery · New York, NY $1,173,636 81% · 1 payment
  2. Christopher Ahmad Orthopaedic Surgery · New York, NY $279,974 19% · 4 payments

Each share is of general payments naming this product in 2023.

Specialties paid General payments · program year 2023
  1. Orthopaedic Surgery $1,453,609 100% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. New York $1,453,609 100% · 2 recipients

Each share is of general payments naming this product in 2023 where a state was reported.

36 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record